An Evolutionarily Conserved N-terminal Acetyltransferase Complex Associated with Neuronal Development

Naoaki Sugiura, Suzanne M. Adams, Roderick A. Corriveau

Journal of Biological Chemistry · 2003 · 95 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

We previously identified mNAT1 (murine N-terminal acetyltransferase 1) as an embryonic gene that is expressed in the developing brain and subsequently down-regulated, in part, by the onset of N-methyl-d-aspartate (NMDA) receptor function. By searching the data base we discovered a second closely related gene, mNAT2. mNAT1 and mNAT2 are highly homologous to yeast NAT1, a gene known to regulate entry into the G0 phase of the cell cycle. However, in the absence of further characterization, including evidence that mammalian homologues of NAT1 encode functional acetyltransferases, the significance of this relationship has been unclear. Here we focus on mNAT1. Biochemical analysis demonstrated that mNAT1 and its evolutionarily conserved co-subunit, mARD1, assemble to form a functional acetyltransferase. Transfection of mammalian cells with mNAT1 and mARD1 followed by immunofluorescent staining revealed that these proteins localize to the cytoplasm in both overlapping and separate compartments. In situ hybridization demonstrated that throughout brain development mNAT1 and mARD1 are highly expressed in areas of cell division and migration and are down-regulated as neurons differentiate. Finally, mNAT1 and mARD1 are expressed in proliferating mouse P19 embryonic carcinoma cells; treatment of these cells with retinoic acid initiates exit from the cell cycle, neuronal differentiation, and down-regulation of mNAT1 and mARD1 as the NMOA receptor 1 gene is induced. The results provide the first direct evidence that vertebrate homologues of NAT1 and ARD1 form an evolutionarily conserved N-terminal acetyltransferase and suggest that expression and down-regulation of this enzyme complex plays an important role in the generation and differentiation of neurons. We previously identified mNAT1 (murine N-terminal acetyltransferase 1) as an embryonic gene that is expressed in the developing brain and subsequently down-regulated, in part, by the onset of N-methyl-d-aspartate (NMDA) receptor function. By searching the data base we discovered a second closely related gene, mNAT2. mNAT1 and mNAT2 are highly homologous to yeast NAT1, a gene known to regulate entry into the G0 phase of the cell cycle. However, in the absence of further characterization, including evidence that mammalian homologues of NAT1 encode functional acetyltransferases, the significance of this relationship has been unclear. Here we focus on mNAT1. Biochemical analysis demonstrated that mNAT1 and its evolutionarily conserved co-subunit, mARD1, assemble to form a functional acetyltransferase. Transfection of mammalian cells with mNAT1 and mARD1 followed by immunofluorescent staining revealed that these proteins localize to the cytoplasm in both overlapping and separate compartments. In situ hybridization demonstrated that throughout brain development mNAT1 and mARD1 are highly expressed in areas of cell division and migration and are down-regulated as neurons differentiate. Finally, mNAT1 and mARD1 are expressed in proliferating mouse P19 embryonic carcinoma cells; treatment of these cells with retinoic acid initiates exit from the cell cycle, neuronal differentiation, and down-regulation of mNAT1 and mARD1 as the NMOA receptor 1 gene is induced. The results provide the first direct evidence that vertebrate homologues of NAT1 and ARD1 form an evolutionarily conserved N-terminal acetyltransferase and suggest that expression and down-regulation of this enzyme complex plays an important role in the generation and differentiation of neurons. Over half of all eukaryotic proteins are N-terminally acetylated (1Polevoda B. Sherman F. J. Biol. Chem. 2000; 275: 36479-36482Abstract Full Text Full Text PDF PubMed Scopus (275) Google Scholar). A functional role for this highly prevalent post-translational modification has been demonstrated for the activity of two peptide hormones; the N-terminal acetyl group of α-melanocorticotropin is necessary for its melanocyte-stimulating activity (2Ney R.L. Ogata E. Shizume N. Nickolson W.E. Liddle G.W. Proc. Int. Congr. Endocrinol. 1964; 2: 1184Google Scholar), and N-terminal acetylation of β-endorphin abolishes its analgesic action (3Symth D.G. Massey D.E. Zakarian S. Finnie M.D. Nature. 1979; 279: 252-254Crossref PubMed Scopus (220) Google Scholar). Apart from such rare exceptions, the biological significance of N-terminal acetylation in higher eukaryotes is unknown. In contrast, considerably more is understood about the role of N-terminal acetylation in Saccharomyces cerevisiae, where three N-terminal acetyltransferases that act on distinct groups of substrates have been identified (4Polevoda B. Norbeck J. Takakura H. Blomberg A. Sherman F. EMBO J. 1999; 18: 6155-6168Crossref PubMed Scopus (171) Google Scholar). One of these enzymes, NatA, is a complex composed of two proteins, NAT1 and ARD1 (5Park E.C. Szostak J.W. EMBO J. 1992; 11: 2087-2093Crossref PubMed Scopus (136) Google Scholar). The nat1 null mutant displays slow growth, derepression of the silent mating locus HML, failure to enter G0, and failure to sporulate (6Mullen J.R. Kayne P.S. Moerschell R.P. Tsunasawa S. Gribskov M. Colavito-Shepanski M. Grunstein M. Sherman F. Sternglanz R. EMBO J. 1989; 8: 2067-2075Crossref PubMed Scopus (241) Google Scholar). An identical phenotype is displayed by strains with a null mutation of ard1 (7Whiteway M. Freedman R. Van Arsdell S. Szostak J.W. Thorner J. Mol. Cell. Biol. 1987; 7: 3713-3722Crossref PubMed Scopus (73) Google Scholar, 8Whiteway M. Szostak J.W. Cell. 1985; 43: 483-492Abstract Full Text PDF PubMed Scopus (105) Google Scholar). Therefore, it has been proposed that in yeast the NAT1/ARD1 complex is required to regulate some protein or proteins involved in cell cycle control (6Mullen J.R. Kayne P.S. Moerschell R.P. Tsunasawa S. Gribskov M. Colavito-Shepanski M. Grunstein M. Sherman F. Sternglanz R. EMBO J. 1989; 8: 2067-2075Crossref PubMed Scopus (241) Google Scholar). Electrical activity mediated by the N-methyl-d-aspartate (NMDA) 1The abbreviations used are: NMDA, N-methyl-d-aspartate; NMDAR, NMDA receptor; E, embryonic day; P, postnatal day; m, mouse; HA, hemagglutinin; MT, Myc-tagged; EST, expressed sequence tag; PBS, phosphate-buffered saline; RIPA, radioimmune precipitation assay.1The abbreviations used are: NMDA, N-methyl-d-aspartate; NMDAR, NMDA receptor; E, embryonic day; P, postnatal day; m, mouse; HA, hemagglutinin; MT, Myc-tagged; EST, expressed sequence tag; PBS, phosphate-buffered saline; RIPA, radioimmune precipitation assay. class of glutamate receptors in the developing brain has been shown to play a role in neuronal survival (9Ikonomidou C. Bosch F. Miksa M. Bittigau P. Vockler J. Dikranian K. Tenkova T.I. Stefovska V. Turski L. Olney J.W. Science. 1999; 283: 70-74Crossref PubMed Scopus (1673) Google Scholar), migration (10Komuro H. Rakic P. J. Neurobiol. 1998; 37: 110-130Crossref PubMed Scopus (236) Google Scholar), proliferation (11Gould E. Cameron H.A. Behav. Neurosci. 1997; 111: 49-56Crossref PubMed Scopus (53) Google Scholar), the formation of precise neural circuits (12Goodman C.S. Shatz C.J. Cell. 1993; 72: 77-98Abstract Full Text PDF PubMed Scopus (1008) Google Scholar, 13Constantine-Paton M. Cline H.T. Curr. Opin. Neurobiol. 1998; 8: 139-148Crossref PubMed Scopus (194) Google Scholar), and has been implicated in fetal alcohol syndrome (14Ikonomidou C. Bittigau P. Ishimaru M.J. Wozniak D.F. Koch C. Genz K. Price M.T. Stefovska V. Horster F. Tenkova T. Dikranian K. Olney J.W. Science. 2000; 287: 1056-1060Crossref PubMed Scopus (1193) Google Scholar) and schizophrenia (15Mohn A.R. Gainetdinov R.R. Caron M.G. Koller B.H. Cell. 1999; 98: 427-436Abstract Full Text Full Text PDF PubMed Scopus (889) Google Scholar). Influx of calcium through activated NMDA receptors initiates intracellular signaling cascades that lead to changes in the activity of transcription factors such as cAMP-responsive element-binding protein and ultimately to changes in gene expression (16West A.E. Chen W.G. Dalva M.B. Dolmetsch R.E. Kornhauser J.M. Shaywitz A.J. Takasu M.A. Tao X. Greenberg M.E. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 11024-11031Crossref PubMed Scopus (830) Google Scholar). Moreover, in the adult hippocampus NMDA receptor-induced changes in gene expression are thought to be necessary for long term changes in synaptic efficacy (17Poser S. Storm D.R. Int. J. Dev. Neurosci. 2001; 19: 387-394Crossref PubMed Scopus (103) Google Scholar). To identify molecular events regulated by NMDA receptor function in developing neurons, we used the disrupted whisker representation neural circuit in NMDAR1 knockout mice (18Li Y. Erzurumlu R.S. Chen C. Jhaveri S. Tonegawa S. Cell. 1994; 76: 427-437Abstract Full Text PDF PubMed Scopus (382) Google Scholar) as model for cDNA microarray analysis. Three genes were identified that are expressed at higher than normal levels in the absence of functional NMDA receptors (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). One of these, mNAT1, is highly homologous to the S. cerevisiae N-terminal acetyltransferase subunit NAT1 (6Mullen J.R. Kayne P.S. Moerschell R.P. Tsunasawa S. Gribskov M. Colavito-Shepanski M. Grunstein M. Sherman F. Sternglanz R. EMBO J. 1989; 8: 2067-2075Crossref PubMed Scopus (241) Google Scholar). In addition to mNAT1, other vertebrate homologues of NAT1 have been identified in screens for molecules expressed very early in embryogenesis (20Choi S.C. Chang J.Y. Han J.K. Biochem. Biophys. Res. Commun. 2001; 285: 1338-1343Crossref PubMed Scopus (5) Google Scholar), as well as in developing blood vessels (21Gendron R.L. Adams L.C. Paradis H. Dev. Dyn. 2000; 218: 300-315Crossref PubMed Scopus (52) Google Scholar). Based on these observations, it has been suggested that these genes encode an N-terminal acetyltransferase that plays an important developmental role that is evolutionarily conserved from lower eukaryotes to mammals. However, in the absence of detailed developmental studies, full-length coding sequence for mammalian NAT1, and biochemical and functional evidence that it an the of this has been unclear. Here we for the first that mammalian NAT1 and mammalian ARD1 to form a functional acetyltransferase. In we that mNAT1 and mARD1 are expressed in of cell division and migration throughout brain development and are down-regulated as neurons and form of synaptic expression and neuronal is in retinoic P19 embryonic carcinoma cells that are neuronal differentiation in The results suggest that an N-terminal acetyltransferase complex mNAT1 and mARD1 an developmental in lower eukaryotes and used in the mammalian cDNA and cDNA sequence for mNAT1 from two overlapping cDNA and as well as from three and To and were on and these were used to an mouse cDNA be that and are cDNA The coding sequence in on both The mNAT1 cDNA sequence has been in the data base An that full-length mNAT1 by a three of the from the from and the from used for expression and of and by the from the and of the H. Dev. 1994; 8: PubMed Scopus Google Scholar, R.A. L. H. Dev. 1994; 8: PubMed Scopus Google Scholar). the of this with the of to A used for in of mNAT1, as well as some acetyltransferase by the cDNA in the control with the from A second used for in of mNAT1 and the of the acetyltransferase by the from into the of and mARD1 to form a functional acetyltransferase. mNAT1 and mARD1 were in in the of to form and proteins, The of protein in of the of protein used in both mNAT1 and mARD1 the two were that in of protein for the or ARD1 from the activity by with and The acetylated peptide by and for mNAT1 is functional in the absence of mNAT1 and were in in the of and both mNAT1 and mARD1 of protein for the or mARD1 is has acetyltransferase displays levels of mNAT1 and mARD1 in and were expressed in embryonic from and cells and to analysis were and to a and the with followed by an and for in as well as in in with for or from cells for from cells The shown in 1 of the of used in A cDNA mARD1 identified in the data base by searching for homologous to yeast The mARD1 cDNA by postnatal mouse brain and the The cDNA into and of to and The has a to the of the mARD1 The full-length mARD1 cDNA into H. Dev. 1994; 8: PubMed Scopus Google Scholar, R.A. L. H. Dev. 1994; 8: PubMed Scopus Google Scholar) to used for mouse from adult with 1 of cDNA in at for The and at for The cDNA were used to mARD1, the from of and the from In situ hybridization as (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar, J. 1989; Google Scholar, R.A. Shatz C.J. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). used are as mNAT1, of and mARD1, of an to as a of P19 P19 embryonic carcinoma cells were and neuronal differentiation in the of retinoic acid as previously M.A. and A Scholar). P19 cells were at a of 1 in the of 1 retinoic acid in were and in and on retinoic the with the for to for a of in retinoic acid treatment and in from the cells and analysis as previously (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar, R.A. J. Neurosci. 1993; PubMed Google Scholar). The were at to and were from the an Storm used are as mNAT1, of mARD1, of an to of NMDAR1 knockout (18Li Y. Erzurumlu R.S. Chen C. Jhaveri S. Tonegawa S. Cell. 1994; 76: 427-437Abstract Full Text PDF PubMed Scopus (382) Google Scholar) were by and as (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). of mARD1 and cells were in fetal and cells were on the of and were into the cells the cells were and by in for and with in for were used at and followed by an at a of mouse used at a of followed by at a of were a with a in are of for of these the cells were with in for with in for and with in for than the treatment results were with both in the of a mNAT1 and mARD1 proteins were and of in protein by of the mNAT1 of the of and of and on for this of and of protein were and the on for The protein were with and in of and were on an from mammalian cells as embryonic cells were on at were with of and the cells were in of and 1 The through a and on for and the by with and protein on for of the with 1 of on for of protein A to the and the for with The were with and in of The mNAT1 protein in the a of the on a to an and with The and the activity A and were in in of mNAT1 and mARD1 as of mNAT1 of mARD1 of of and of protein were on for The complex to the by and three with and with N-terminal acetyltransferase activity as previously J. Biol. Chem. Full Text PDF PubMed Google Scholar, R. R.A. PubMed Scopus Google Scholar), with some the complex at for in a and with The and of to of in The three with 1 of acid and with of and by of previously identified a cDNA to the of mNAT1, it is expressed at higher than normal levels in the developing of NMDAR1 knockout mice (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). To full-length cDNA to mNAT1, we a mouse cDNA and analysis that this the of the coding from and An of an acid protein from the sequence mNAT1 and yeast NAT1 and acid are One to be identical in sequence to that from and with the of the and a silent at of the cDNA sequence of the to the mouse sequence that an that from of an a protein that is at the than the by the other we A of the data base identified a cDNA that a mouse protein that is identical to mNAT1 acid are the is analysis of mNAT2 in the levels of expression are in the and expression in the and the expression of mNAT1 and mNAT2 are expression levels of mNAT2 are lower than of mNAT1, in in the brain N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). Therefore, the analysis on mNAT1. A of in S. cerevisiae demonstrated to form a functional N-terminal acetyltransferase NAT1 assemble with gene ARD1 (5Park E.C. Szostak J.W. EMBO J. 1992; 11: 2087-2093Crossref PubMed Scopus (136) Google Scholar). the mouse of ARD1 has been we a mouse cDNA in that a protein that with yeast Based on this were to mouse ARD1 in two of and base analysis of these revealed that the of the two is identical to the to be from an with an to of of these two cDNA with the mouse sequence that from an of in the coding analysis that in mouse brain the form is expressed at higher levels than the The expression of mARD1 in adult mouse by analysis mARD1 is expressed and in displays a of expression to that for mNAT1 (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). An to this is in the where mNAT1 expression is mARD1 expression is In mNAT1 (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar), mARD1 is expressed at normal levels in the and brain of NMDAR1 knockout mice of mNAT1 and mARD1 in the demonstrated that in mouse levels of mNAT1 expression are in that proliferating and the and (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). analysis that as development expression of mNAT1 in the brain (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). To mNAT1 and mARD1 are expressed in in neuronal and neurons throughout we in situ hybridization analysis on brain from embryonic to mNAT1 is expressed at levels throughout the neural of the is by proliferating and cell the of the brain at and mNAT1 expression By mNAT1 expression has in of the and where neurons are and and have in to In contrast, expression is at levels in the and where cell division and migration are in the By mNAT1 expression is throughout of the expression is in the hippocampus and the expression at is in to that at The expression of mARD1 is to that for mNAT1. mNAT1, mARD1 is expressed throughout the developing brain from through However, it is expressed at lower levels and in a at and mNAT1, mARD1 to be expressed throughout the brain at and in a that for mNAT1 at and with levels of expression and higher levels in the and of the of mNAT1 and mARD1 in P19 P19 embryonic carcinoma cells are cells that be to exit the cell cycle and a phenotype by as an in the of retinoic acid M.A. and A Scholar). neuronal differentiation, P19 cells to neuronal including acid J.M. Res. Mol. Res. 1993; PubMed Scopus Google Scholar), M. C. Dev. Biol. 1989; PubMed Scopus Google Scholar), NMDA and glutamate receptors Biochem. Biophys. Res. Commun. 1993; PubMed Scopus Google Scholar, S. 1997; PubMed Scopus Google Scholar). We from P19 cells at of differentiation and used to changes in levels for mNAT1, and in Biochem. Biophys. Res. Commun. 1993; PubMed Scopus Google Scholar, S. 1997; PubMed Scopus Google Scholar), NMDAR1 in P19 cells and is as differentiation In contrast, mNAT1 and mARD1 are expressed at levels the addition of retinoic the of cells that treatment with retinoic acid M.A. and A Scholar), both mNAT1 and mARD1 by at the of the of expression for mNAT1, and mARD1 are is brain mNAT1 and mARD1 expression as NMDAR1 expression (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). of mNAT1 and cells were with mNAT1 and the cells were with mouse and followed by with or of mNAT1 and mARD1 by proteins in the cytoplasm and are from the some in are in separate compartments. mNAT1 is to the in a mARD1 is from the cytoplasm to to the where in some cells it a of mNAT1 and mARD1 in this of mARD1 and An and mARD1 were in and the were To separate complex from the acetyltransferase mARD1 an analysis of the that mNAT1 with mARD1 to form a complex activity and a peptide of that has been used in N-terminal acetyltransferase J. Biol. Chem. Full Text PDF PubMed Google Scholar). The complex displayed acetyltransferase activity more than In contrast, activity in in ARD1 or the with To mNAT1 mARD1 to form a functional as is the for yeast NAT1 (5Park E.C. Szostak J.W. EMBO J. 1992; 11: 2087-2093Crossref PubMed Scopus (136) Google Scholar), we mNAT1 with a mNAT1 that be for acetyltransferase activity of mARD1 and mARD1 an The results suggest that mNAT1 the of mARD1 to be Finally, a the of mNAT1 and mARD1 is these proteins in Therefore, embryonic cells were with and mNAT1. mARD1 from the cell an an to mNAT1 with The of mNAT1 on the that mNAT1 and mARD1 in mammalian development is by changes in the and of neural as exit the cell cycle, from the and highly events this are of in neuronal development have for function. of functional NMDA receptors lead to of the synaptic to form in the brain and synaptic circuits are disrupted that the (18Li Y. Erzurumlu R.S. Chen C. Jhaveri S. Tonegawa S. Cell. 1994; 76: 427-437Abstract Full Text PDF PubMed Scopus (382) Google Scholar, M. L. M. T. 1994; Full Text PDF PubMed Scopus Google Scholar, C.S. J. J. Neurosci. 2000; PubMed Google Scholar). To identify genes regulated by NMDA receptors in developing neurons, we used cDNA microarray analysis to gene expression the developing brain of and NMDAR1 knockout mice (19Sugiura N. Patel R.G. Corriveau R.A. J. Biol. Chem. 2001; 276: 14257-14263Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). We discovered a group of three genes that are expressed at levels early in development and down-regulated, in part, by NMDA receptor function as the brain One of these, mNAT1, is homologous to yeast NAT1, a protein known to with ARD1 to form an N-terminal acetyltransferase have shown that NAT1 and ARD1 regulate a of events the S. cerevisiae cycle, including entry into the G0 phase of the cell cycle (6Mullen J.R. Kayne P.S. Moerschell R.P. Tsunasawa S. Gribskov M. Colavito-Shepanski M. Grunstein M. Sherman F. Sternglanz R. EMBO J. 1989; 8: 2067-2075Crossref PubMed Scopus (241) Google Scholar, M. Freedman R. Van Arsdell S. Szostak J.W. Thorner J. Mol. Cell. Biol. 1987; 7: 3713-3722Crossref PubMed Scopus (73) Google Scholar, 8Whiteway M. Szostak J.W. Cell. 1985; 43: 483-492Abstract Full Text PDF PubMed Scopus (105) Google Scholar). Here we the first evidence that mammalian homologues of NAT1 and ARD1 to form a functional acetyltransferase. Moreover, throughout brain as well as in P19 expression of these genes is with of or Based on these results we that an N-terminal acetyltransferase of mNAT1 and mARD1 plays an important role in neural and that down-regulation of these genes is required for neuronal A of the data base that are at two mouse homologues of yeast mNAT1 and mNAT2. genes identical levels of to yeast NAT1 have two homologues of NAT1, that the gene that two NAT1 homologues to the of mammals. The significance of two homologues of NAT1 is In the focus on mNAT1, it is in NMDAR1 knockout and it to be expressed at higher levels than mNAT2. of the functional significance of mouse homologues of NAT1 that the of both mNAT1 and mNAT2 be into of mNAT1 and mARD1 in a cell revealed overlapping separate of these two are in the cytoplasm and from the mNAT1 is in a mARD1 is from the cytoplasm to the The of of the of these two proteins function and is mNAT2 in the cell in where mNAT1 is the levels of acetyltransferase as well as the of and the In in NAT1 assemble with ARD1 to be functional (5Park E.C. Szostak J.W. EMBO J. 1992; 11: 2087-2093Crossref PubMed Scopus (136) Google Scholar). To to the of the of is the in the cell where mNAT1, with mARD1, functional N-terminal we used in with an acetyltransferase assay. In to has been for a N-terminal acetyltransferase that a of with yeast NAT1 R. R.A. PubMed Scopus Google Scholar), including as well as we acetyltransferase activity with mNAT1 in the absence of that the on the of mNAT1 its acetyltransferase activity its activity with However, a more is that mNAT1, yeast NAT1, is functional on its mNAT1 and mARD1 are expressed at levels in neural and down-regulated neuronal is the in the as well as in mouse embryonic carcinoma P19 cells with retinoic these cells to and neuronal including NMDA is that a of mNAT1 and mARD1 expression in P19 at the of the the of retinoic acid One is that expression of these genes is in a of cells that to retinoic acid M.A. and A Scholar). some expression of mNAT1 and mARD1 be differentiation of retinoic P19 cells is and are neurons. In the an to the that mNAT1 and mARD1 are down-regulated development is in the where adult levels of expression of both genes are as as at the hippocampus is a of and synaptic in the Moreover, some expression of mNAT1 is in the adult of synaptic the results are with the that mNAT1 is a for cells that are the to or long term changes in synaptic or function. The the first direct evidence that mammalian NAT1 and mammalian ARD1 to form a functional and evolutionarily conserved N-terminal acetyltransferase. However, it is to the relationship these proteins and yeast into conserved developmental significance for the yeast NAT1 entry into the G0 phase of the cell cycle. the expression in as well as blood vessels (21Gendron R.L. Adams L.C. Paradis H. Dev. Dyn. 2000; 218: 300-315Crossref PubMed Scopus (52) Google Scholar), are with a role for mNAT1 in mammalian this has been focus on the by mNAT1 and mARD1 in neural the for and of down-regulation of these genes and the significance of mNAT2. We for the of as well as of a Patel for and for with

References

32